SOFAR SWISS SA
CH-MF-000047475 · Switzerland · Lugano
SOFAR SWISS SA is registered in the European database on medical devices as a manufacturer, with 34 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class I | 34 |
|---|
Most frequent device types declared: MELT IN MOUTH TABLETS, Oral solution, sachets of 10ml, oral solution, sachets of 10 ml, oral solution, sachets of 10ml.
Authorised representative in the Union: ALFASIGMA S.P.A..
Devices declared under this manufacturer
- ESOXX DEFENCE
- ESOXX PROTECTION
- ESOXX DEFENCE
- ESOXX REFLUX DEFENCE
- ESOXX REFLUX PROTECTION
- ESOXX REFLUX PROTECTION & ACID DEFENCE
- GERDOFF
- GERDOFF PROTECTION
- GERDOFF DUO
- GERDOFF PLUS
- GERDOFF PROTECTION
- REFLUZERO
Showing 12 of 34 declared devices.
Catalogue references include ES-C04L, EXX-C04L, EXX-C20L, GF-C04L, GF-C20L, GFD-C20L.
European nomenclature codes declared: G99.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 34 |
| Country of registration | Switzerland |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 34 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. SOFAR SWISS SA was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
CVD0045250125 | supplemented | 2030-04-23 |
CVD0043250725 | supplemented | 2030-04-23 |
CSQ0028250925 | supplemented | 2030-04-23 |